New Alzheimer's Disease Indicator
Researchers from Switzerland may have uncovered a breakthrough in diagnosing Alzheimer?s disease. Using this test would allow physicians to start treating patients earlier to minimize the symptoms.
By analyzing a patient?s spinal fluid, Odile Carrette, PhD, a researcher at Geneva University Hospital, discovered that Alzheimer?s patients have certain proteins that mark the disease. She found 17 protein markers that are exhibited in higher levels in Alzheimer?s patients, compared with healthy patients. To test the findings, Dr. Carrette conducted a study with 20 participants. She correctly identified 9 of 10 patients with the disease and ruled out the 10 participants who did not have the disease. The more protein markers a patient had, the more likely it was that he or she would develop the disease.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025